One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Micronutrient Status and Prediction of Disease Outcome in Adults With Inflammatory Bowel Disease Receiving Biologic Therapy
doi : 10.1093/ibd/izad174
Volume 30, Issue 8, August 2024
Dietary Emulsifier Exposure in People With Inflammatory Bowel Disease Compared With Healthy Controls: Is There a Cause for Concern?
doi : 10.1093/ibd/izad318
Causal Association Analysis of Periodontitis and Inflammatory Bowel Disease: A Bidirectional Mendelian Randomization Study
doi : 10.1093/ibd/izad188
Nationwide Real-World Exclusive Enteral Nutrition Practice Over Time: Persistence of Use as Induction for Pediatric Crohn’s Disease and Emerging Combination Strategy With Biologics
doi : 10.1093/ibd/izad167
Children and Young Adults With Inflammatory Bowel Disease Have an Increased Incidence and Risk of Developing Mental Health Conditions: A UK Population-Based Cohort Study
doi : 10.1093/ibd/izad169
Inflammatory Bowel Disease Is an Independent Risk Factor for Metabolic Dysfunction–Associated Steatotic Liver Disease in Lean Individuals
doi : 10.1093/ibd/izad175
Safety, Effectiveness, and Treatment Persistence of Subcutaneous Vedolizumab in IBD: A Multicenter Study From the United Kingdom
doi : 10.1093/ibd/izad166
Efficacy of Ustekinumab Optimization by 2 Initial Intravenous Doses in Adult Patients With Severe Crohn’s Disease
doi : 10.1093/ibd/izad184
A Treat-to-Target Strategy Guided by Pan-Enteric Evaluation in Children With Crohn’s Disease Improves Outcomes at 2 Years
doi : 10.1093/ibd/izad173
Vascular Disease Is Associated With Differences in Brain Structure and Lower Cognitive Functioning in Inflammatory Bowel Disease: A Cross-Sectional Study
doi : 10.1093/ibd/izad204
Gastroenterology Clinic Follow-Up Reduces Gastroenterology-Specific Readmissions Among Patients With Severe Ulcerative Colitis
doi : 10.1093/ibd/izad207
Extensive Colitis and Smoking Are Associated With Postoperative Complications Within 30 Days of Ileal Pouch–Anal Anastomosis
doi : 10.1093/ibd/izad177
Predictors of Hospital-related Outcomes of COVID-19 Infection in Patients With Inflammatory Bowel Disease in the Early Pandemic Phase: A Nationwide Inpatient Database Survey
doi : 10.1093/ibd/izad200
Corticosteroids but not Anti-TNF Are Associated With Increased COVID-19 Complications in Patients With Inflammatory Bowel Disease
doi : 10.1093/ibd/izad176
Monoclonal Antibody Against Mature Interleukin-18 Ameliorates Colitis in Mice and Improves Epithelial Barrier Function
doi : 10.1093/ibd/izad292
Phosphoproteomics Reveals Novel Insights into the Pathogenesis and Identifies New Therapeutic Kinase Targets of Ulcerative Colitis
doi : 10.1093/ibd/izad291
Crohn’s Disease–Associated Pathogenic Mutation in the Manganese Transporter ZIP8 Shifts the Ileal and Rectal Mucosal Microbiota Implicating Aberrant Bile Acid Metabolism
doi : 10.1093/ibd/izae003
Factors Associated With Response to Rescue Therapy in Acute Severe Ulcerative Colitis
doi : 10.1093/ibd/izad183
Hypoxic Functional Regulation Pathways in the GI Tract: Focus on the HIF-1α and Microbiota’s Crosstalk
doi : 10.1093/ibd/izae046
1-Year Comparison of Clinical and Endoscopic Outcomes of Tofacitinib vs Vedolizumab for Ulcerative Colitis After Anti-Tumor Necrosis Factor Failure: A Real-World Cohort Study in the United States
doi : 10.1093/ibd/izad165
Pouch Body Anastomotic Ulcerations Are Not Associated With an Increased Risk of Pouchitis
doi : 10.1093/ibd/izad172
Prevalence and Treatment Patterns of Inflammatory Bowel Disease in the All of Us Research Program
doi : 10.1093/ibd/izad170
Postvaccination Symptoms After a Fourth Dose of mRNA SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease
doi : 10.1093/ibd/izad198
Pneumocystis jirovecii Pneumonia Complicating Use of Upadacitinib in a Patient With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Case Report
doi : 10.1093/ibd/izae091
Transperineal Ultrasonography in the Assessment of Rectal Inflammation: Beyond the Monitoring of Ulcerative Colitis
doi : 10.1093/ibd/izad254
Evaluating Serum Free Thiols in Inflammatory Bowel Disease: Contribution of Albumin to Extracellular Free Thiol Status
doi : 10.1093/ibd/izae102
Authors’ Response to Letter to Editor: “Evaluating Serum Free Thiols in Inflammatory Bowel Disease: Contribution of Albumin to Extracellular Free Thiol Status�
doi : 10.1093/ibd/izae108
